SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced the CE marking of its SYNTAX System, the first EDS-powered benchtop DNA printer.
Fully automated SYNTAX platform features latest STX-200 system, enzymatic biochemistry advances, and ready-to-use reagents for producing up to 96 oligos that are up to 120 nt long in less than a day ...
The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in ...
The benchtop DNA printer developer DNA Script has expanded upon its most recent venture capital funding round, tacking on an additional $35 million for a grand total of $200 million. The financing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The microwave-sized device will allow researchers to print ...
Following the launch of its benchtop DNA printer earlier this year, DNA Script has secured a hefty $165 million to take its platform to the masses. The nine-digit proceeds represent a big leap in DNA ...
There is so much happening in the field of DNA synthesis these days that it can be hard to keep up. Just a few weeks ago, synthetic biology startup Molecular Assemblies announced that they are ...
DNA Script SAS raised a $50 million extension to its series B financing, for a total yield of $89 million. Paris-based DNA Script has earmarked the funds to advance the development of its suite of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback